Rheumatoid Arthritis Treatment Guidelines

Initial Steroid Approach

The American College of Rheumatology recommends considering low-dose glucocorticoids (≤10 mg/day of prednisone or equivalent) as a short-term adjunct to disease-modifying antirheumatic drugs (DMARDs) in patients with moderate to high RA disease activity, to provide the best benefit-risk ratio 1, 2
Short-term glucocorticoids (defined as <3 months treatment) should be considered for RA disease flares, according to the American College of Rheumatology 1
Systemic glucocorticoids are effective for short-term relief of signs and symptoms and may help retard radiographic progression in early and established RA, as stated by the European League Against Rheumatism 3, 4

For patients with isolated joint inflammation, consider intra-articular glucocorticoid injections rather than increasing systemic dose, as recommended by the American College of Rheumatology 5, 6
Among intra-articular corticosteroids, triamcinolone hexacetonide appears to be the most effective option, according to the European League Against Rheumatism 3

Glucocorticoid therapy should be temporary due to potential side effects, as stated by the American College of Rheumatology and the European League Against Rheumatism 1, 3
After the first 1-2 years, the benefits of long-term corticosteroid therapy are often outweighed by risks including cataracts, osteoporosis, and potentially cardiovascular disease, according to the Mayo Clinic Proceedings 6
In patients who achieve remission, tapering and discontinuing prednisone should be prioritized, as recommended by the American College of Rheumatology and the Mayo Clinic Proceedings 5, 7

Methotrexate is considered the anchor drug for RA treatment, with glucocorticoids serving as adjunctive therapy, as stated by the European League Against Rheumatism 4
Combination therapy including steroids may be more effective in terms of radiographic progression than single DMARD therapy, according to the European League Against Rheumatism 3

Monitor for potential side effects including weight gain, hypertension, diabetes, cataracts, and osteoporosis, as recommended by the European League Against Rheumatism 3
The risk/benefit ratio of glucocorticoid therapy is favorable as long as the dose is low and the duration of therapy is short, according to the American College of Rheumatology 1